Stefan Vitorovic MS, MBA

Stefan Vitorovic is Co‐Founder and Managing Director of Vida Ventures, a life sciences focused venture capital firm. From 2014 to 2017, Stefan was an investment professional at Third Rock Ventures, an early stage life sciences venture capital firm. At Third Rock, Stefan focused on new company formation, due diligence, portfolio company financings, and partner development. He was part of the founding team of Decibel Therapeutics, a hearing‐focused drug discovery and development platform company, where he led the seed and Series A investment. Stefan worked full‐time at Decibel, including start‐up operations, business development, and strategy; he transitioned the company to its permanent management team in late 2016.

From 2010 to 2012, Stefan was an Associate at TPG Capital, where he focused primarily on majority, control stakes in mature healthcare companies. Stefan participated in a variety of equity and debt financings, including those for two of his portfolio companies ‐ Aptalis and Biomet. Prior to TPG, Stefan was an analyst at Credit Suisse’s healthcare investment banking group in San Francisco. There he primarily focused on M&A and financing for development‐stage life sciences companies; he also led the firm’s West Coast recruiting efforts.

Stefan received his B.S. with Honors in Biological Sciences at Stanford University. He completed his M.S. in Biology at Stanford. His research in the lab of Dr. Helen Blau at Stanford Medical School was focused on transcriptional profiling of hematopoietic stem cells, for which he received the university’s top research award, The Firestone Medal. Stefan also received his MBA from Harvard Business School.

Stefan was born in Belgrade, Serbia; he migrated to the U.S. at the age of 8. He currently lives in Boston.